Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma (PRP) injections successfully treated a woman's steroid-resistant hair loss, causing hair to regrow within a month.

CD2 might be a new treatment target for patchy alopecia areata.

Insulin therapy helped a man with autoimmune issues regrow his hair.

Vitiligo and alopecia areata might be early signs of Type 1 Diabetes.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

The girl's regrown brown hair had less of certain pigments than her original black hair.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

A 24-year-old man developed both alopecia areata universalis and type 1 diabetes at the same time, which is rare.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

A woman with type 2 diabetes developed alopecia areata, suggesting a link between the two autoimmune conditions.

Botulinum toxin type A injections are not effective for severe alopecia areata.

Lower MC2R expression may contribute to alopecia areata.

Patients with Type 1 diabetes should be screened for pernicious anemia.

Alopecia areata may involve stress-related changes affecting hormone receptors, leading to reduced cortisol production.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

Fexofenadine may help treat a difficult type of hair loss.

A patient with a rare chromosome condition also had a rare type of hair loss.

Atopic diseases worsen alopecia areata, leading to earlier onset and more severe forms.

New treatment for hair loss using special microneedles shows promise in reducing inflammation and promoting hair growth.

A woman with multiple autoimmune diseases showed improvement in hair loss but not in skin discoloration after treatment.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Innate lymphoid cells type 1 may contribute to alopecia areata.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

Tofacitinib may help treat severe hair loss, but more research is needed.

A patient with leukemia/lymphoma also had multiple autoimmune diseases, suggesting a link between them.

A 22-year-old with multiple autoimmune diseases needs a multidisciplinary treatment approach.

Alopecia areata is more common in young Black African males, with rare other health issues.

Early intervention in patch-type alopecia may prevent progression to more severe forms by targeting immune pathways and preserving keratin.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.